Biography & Research:
Ivana Stojanovic, PhD, is principal investigator and Diabetology team leader at the Department for Immunology, Institute for Biological Research in Belgrade, Serbia. She obtained her PhD in 2004 at the University of Belgrade when she found the crucial role of macrophage migration inhibitory factor in the pathogenesis of type 1 diabetes. Since then, her scientific work focused on various approaches for type 1 diabetes treatment including the generation of insulin-specific T regulatory cells for cell-based therapy of diabetes. She published over 50 articles that were cited over 1200 times (h-index 19). Her recent investigation of the immunological profile of 5xFAD mice (that develop symptoms of Alzheimer's disease) resulted in the important finding that the production of interleukin-17 in the gut immune system is severely impaired in these mice. Low interleukin-17 production could lead to improper immune surveillance of the gut microbiota (that are recently implicated in the development of AD).